• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对乳腺癌患者前哨淋巴结活检结果和生存的影响:一项单中心回顾性研究。

Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single-center retrospective study.

机构信息

Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Department of Breast Surgery, Shanghai Cancer Center, Fudan University, Shanghai, China.

出版信息

Cancer Med. 2024 May;13(9):e7248. doi: 10.1002/cam4.7248.

DOI:10.1002/cam4.7248
PMID:38733197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11087846/
Abstract

BACKGROUND

Sentinel lymph node biopsy (SLNB) is a common choice for axillary surgery in patients with early-stage breast cancer (BC) who have clinically negative lymph nodes. Most research indicates that obesity is a prognostic factor for BC patients, but studies assessing its association with the rate of positive sentinel lymph nodes (SLN) and the prognosis of patients with early BC undergoing SLNB are limited.

METHODS

Between 2013 and 2016, 7062 early-stage BC patients from the Shanghai Cancer Center of Fudan University were included. Based on the Chinese Body Mass Index (BMI) classification standards, the patients were divided into three groups as follows: normal weight, overweight, and obese. Propensity score matching analysis was used to balance the baseline characteristics of the participants. Logistic regression analysis was used to determine the association between obesity and positive SLN rate. Cox regression analysis was used to investigate whether obesity was an independent prognostic factor for early-stage BC patients who had undergone SLNB.

RESULTS

No significant association was observed between obesity and positive SLN rate in early-stage BC patients who had undergone SLNB. However, multivariate analysis revealed that compared to patients with normal BMI, the overall survival (hazard ratio (HR) 2.240, 95% confidence interval (CI) 1.27-3.95, p = 0.005) and disease-free survival (HR 1.750, 95% CI 1.16-2.62, p = 0.007) were poorer in patients with high BMI.

CONCLUSION

Obesity is an independent prognostic factor for early-stage BC patients who undergo SLNB; however, it does not affect the positive SLN rate.

摘要

背景

前哨淋巴结活检(SLNB)是临床腋窝淋巴结阴性的早期乳腺癌(BC)患者腋窝手术的常用选择。大多数研究表明肥胖是 BC 患者的预后因素,但评估其与前哨淋巴结(SLN)阳性率和接受 SLNB 的早期 BC 患者预后之间关系的研究有限。

方法

纳入 2013 年至 2016 年期间来自复旦大学上海癌症中心的 7062 例早期 BC 患者。根据中国 BMI 分类标准,将患者分为三组:正常体重、超重和肥胖。采用倾向评分匹配分析来平衡参与者的基线特征。采用 logistic 回归分析确定肥胖与 SLN 阳性率之间的关联。采用 Cox 回归分析来研究肥胖是否是接受 SLNB 的早期 BC 患者的独立预后因素。

结果

在接受 SLNB 的早期 BC 患者中,肥胖与 SLN 阳性率之间没有显著关联。然而,多变量分析显示,与 BMI 正常的患者相比,肥胖患者的总体生存率(危险比(HR)2.240,95%置信区间(CI)1.27-3.95,p=0.005)和无病生存率(HR 1.750,95% CI 1.16-2.62,p=0.007)较差。

结论

肥胖是接受 SLNB 的早期 BC 患者的独立预后因素;然而,它并不影响 SLN 阳性率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb2/11087846/e456b4f245bb/CAM4-13-e7248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb2/11087846/881cead0c5e1/CAM4-13-e7248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb2/11087846/8e65888f1a92/CAM4-13-e7248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb2/11087846/e456b4f245bb/CAM4-13-e7248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb2/11087846/881cead0c5e1/CAM4-13-e7248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb2/11087846/8e65888f1a92/CAM4-13-e7248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb2/11087846/e456b4f245bb/CAM4-13-e7248-g003.jpg

相似文献

1
Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single-center retrospective study.肥胖对乳腺癌患者前哨淋巴结活检结果和生存的影响:一项单中心回顾性研究。
Cancer Med. 2024 May;13(9):e7248. doi: 10.1002/cam4.7248.
2
Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.1-2 个前哨淋巴结转移的乳腺癌患者 T 分期对腋窝评估方式选择的影响。
Clin Breast Cancer. 2024 Jun;24(4):e232-e243.e1. doi: 10.1016/j.clbc.2024.01.012. Epub 2024 Jan 24.
3
Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.腋窝淋巴结清扫术与前哨淋巴结阳性乳腺癌无腋窝手术的疗效和安全性比较:系统评价和荟萃分析。
BMC Surg. 2023 Jul 26;23(1):209. doi: 10.1186/s12893-023-02101-8.
4
Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.前哨淋巴结活检术在判断腋窝淋巴结转移中的诊断准确性。
J Cancer Res Ther. 2020 Oct-Dec;16(6):1265-1268. doi: 10.4103/jcrt.JCRT_1122_19.
5
Size of Extranodal Extension in the Sentinel Lymph Node as a Predictor of Prognosis in Early-Stage Breast Cancer.前哨淋巴结内的淋巴结外延伸大小可预测早期乳腺癌的预后。
Clin Breast Cancer. 2024 Oct;24(7):e560-e570. doi: 10.1016/j.clbc.2024.05.005. Epub 2024 May 13.
6
De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: The ratio of positive sentinel lymph nodes matters.新辅助化疗后乳腺癌腋窝管理降级:前哨淋巴结阳性比例很重要。
Surg Oncol. 2024 Jun;54:102062. doi: 10.1016/j.suronc.2024.102062. Epub 2024 Mar 13.
7
Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.pN0 期乳腺癌患者前哨淋巴结活检或腋窝淋巴结清扫术后的长期生存:一项基于人群的研究。
Breast Cancer Res Treat. 2022 Dec;196(3):613-622. doi: 10.1007/s10549-022-06746-6. Epub 2022 Oct 7.
8
Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.早期乳腺癌中临床病理特征对前哨淋巴结转移的预测价值。
Med Sci Monit. 2017 Aug 25;23:4102-4108. doi: 10.12659/msm.902795.
9
Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.预测前哨淋巴结阳性乳腺癌患者的额外淋巴结受累。
Neoplasma. 2016;63(3):427-34. doi: 10.4149/312_150922N497.
10
Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database.保乳乳腺癌前哨淋巴结转移的危险因素和预后:基于 SEER 数据库的回顾性研究。
Medicine (Baltimore). 2024 Mar 1;103(9):e37263. doi: 10.1097/MD.0000000000037263.

本文引用的文献

1
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis.体重指数对新辅助靶向治疗的HER2阳性乳腺癌治疗反应的影响:一项多中心研究和荟萃分析。
NPJ Breast Cancer. 2023 May 31;9(1):46. doi: 10.1038/s41523-023-00552-z.
2
Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.体重指数增加术后6至18个月患乳腺癌相关淋巴水肿的风险:一项回顾性研究。
Support Care Cancer. 2023 Apr 19;31(5):278. doi: 10.1007/s00520-023-07721-7.
3
The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study.
体脂肪与乳腺癌幸存者死亡率之间的关联:前瞻性队列研究的结果。
Eur J Epidemiol. 2023 May;38(5):545-557. doi: 10.1007/s10654-023-00979-5. Epub 2023 Mar 29.
4
Excess body weight: Novel insights into its roles in obesity comorbidities.超重:对其在肥胖合并症中作用的新见解。
Semin Cancer Biol. 2023 Jul;92:16-27. doi: 10.1016/j.semcancer.2023.03.008. Epub 2023 Mar 24.
5
Overweight, obesity and risk of multimorbidity: A systematic review and meta-analysis of longitudinal studies.超重、肥胖与多种疾病风险:一项基于纵向研究的系统回顾和荟萃分析。
Obes Rev. 2023 Jun;24(6):e13562. doi: 10.1111/obr.13562. Epub 2023 Mar 16.
6
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.体重指数对乳腺癌患者新辅助化疗反应的预测重要性
Breast Care (Basel). 2023 Feb;18(1):42-48. doi: 10.1159/000526732. Epub 2022 Sep 14.
7
The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.肥胖和内分泌治疗对激素受体阳性绝经前乳腺癌妇女预后的影响:单中心回顾性研究。
Cancer Rep (Hoboken). 2023 Feb;6(2):e1695. doi: 10.1002/cnr2.1695. Epub 2022 Aug 9.
8
Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study.肥胖和代谢状态与增加的医疗资源和药物使用及成本有关:一项芬兰基于人群的研究。
Eur J Health Econ. 2023 Jul;24(5):769-781. doi: 10.1007/s10198-022-01507-0. Epub 2022 Sep 5.
9
Weight Gain after Hormone Receptor-Positive Breast Cancer.激素受体阳性乳腺癌患者的体重增加
Curr Oncol. 2022 Jun 6;29(6):4090-4103. doi: 10.3390/curroncol29060326.
10
Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).非洲裔血统对早期乳腺癌试验(ECOG-ACRIN E5103)中体重指数与生存关系的影响。
Cancer. 2022 Jun 1;128(11):2174-2181. doi: 10.1002/cncr.34173. Epub 2022 Mar 14.